"Once the $200 is gone, beneficiaries still have to pay out of pocket for expensive medications. I don't think anybody looks at this and says that this is a solution to the consumer problem [of high drug prices]."
— Avalere Health founder Dan Mendelson spoke with AIS's RADAR on Drug Benefits
about President Trump's proposal to distribute $200 prescription drug debit
cards to all Medicare Part D enrollees, and why experts think it's a strictly
political move.
No comments:
Post a Comment